Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

German Ott

Showing results (281-290 of 374) with videos related to

Pageof 38
Sort By:
Haematologica|November 3, 2009
SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtypeAna Mozos, Cristina Royo, Elena Hartmann, et al.
Haematologica|August 14, 2008
Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphomaItziar Salaverria, Andreas Zettl, Silvia Beà, et al.
Blood|August 14, 2015
IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphomaChao Wang, Timothy W McKeithan, Qiang Gong, et al.
Blood|October 22, 2005
Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletionsLisa M Rimsza, Robin A Roberts, Elias Campo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2011
BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximabJaveed Iqbal, Paul N Meyer, Lynette M Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2006
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphomaJaveed Iqbal, Vishala T Neppalli, George Wright, et al.
Nature|October 3, 2014
Loss of signalling via Gα13 in germinal centre B-cell-derived lymphomaJagan R Muppidi, Roland Schmitz, Jesse A Green, et al.
Leukemia|August 16, 2024
Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials-a LYSA and GLA/ DSHNHL collaborationFabian Frontzek, Loïc Renaud, Ulrich Dührsen, et al.
Leukemia|August 30, 2023
Frequent ZNF217 mutations lead to transcriptional deregulation of interferon signal transduction via altered chromatin accessibility in B cell lymphomaFranziska Briest, Daniel Noerenberg, Cornelius Hennch, et al.
Genome Medicine|May 2, 2019
A modular transcriptome map of mature B cell lymphomasHenry Loeffler-Wirth, Markus Kreuz, Lydia Hopp, et al.
Pageof 38

Showing results (281-290 of 374) with videos related to

Sort By:
Pageof 38
Haematologica|November 3, 2009
SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtypeAna Mozos, Cristina Royo, Elena Hartmann, et al.
Haematologica|August 14, 2008
Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphomaItziar Salaverria, Andreas Zettl, Silvia Beà, et al.
Blood|August 14, 2015
IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphomaChao Wang, Timothy W McKeithan, Qiang Gong, et al.
Blood|October 22, 2005
Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletionsLisa M Rimsza, Robin A Roberts, Elias Campo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2011
BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximabJaveed Iqbal, Paul N Meyer, Lynette M Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2006
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphomaJaveed Iqbal, Vishala T Neppalli, George Wright, et al.
Nature|October 3, 2014
Loss of signalling via Gα13 in germinal centre B-cell-derived lymphomaJagan R Muppidi, Roland Schmitz, Jesse A Green, et al.
Leukemia|August 16, 2024
Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials-a LYSA and GLA/ DSHNHL collaborationFabian Frontzek, Loïc Renaud, Ulrich Dührsen, et al.
Leukemia|August 30, 2023
Frequent ZNF217 mutations lead to transcriptional deregulation of interferon signal transduction via altered chromatin accessibility in B cell lymphomaFranziska Briest, Daniel Noerenberg, Cornelius Hennch, et al.
Genome Medicine|May 2, 2019
A modular transcriptome map of mature B cell lymphomasHenry Loeffler-Wirth, Markus Kreuz, Lydia Hopp, et al.
Pageof 38